Medical Innovations Patent Mitra: NMC issues advisory for medical colleges on ICMR's initiative
National Medical Commission
New Delhi: The National Medical Commission (NMC) has issued an advisory asking all medical colleges and institutions across the country to promote the Indian Council of Medical Research, ICMR's newly launched 'Medical Innovations Patent Mitra' initiative among faculty members, clinicians, researchers, and students.
The Indian Council of Medical Research (ICMR) has launched the "Medical Innovations Patent Mitra" initiative to strengthen India's biomedical innovation ecosystem by supporting patent protection and technology transfer of healthcare innovations emerging from institutions across the country.
In the advisory issued on July 1, 2026, the NMC said the initiative offers fully government-funded support for patent filing and technology transfer. This will help researchers and innovators protect their intellectual property and convert their research into healthcare products and technologies that can benefit the public.
The Commission said that the initiative is in line with the NMC's objective of promoting research, innovation, and excellence in medical education.
The NMC has asked all medical colleges and institutions to widely share information about the initiative among their faculty members, clinicians, researchers, and students and to encourage innovators to make use of the platform for patent filing and technology transfer.
The Commission further stated that active participation by medical colleges and institutions will help strengthen India's healthcare innovation ecosystem and speed up the translation of research into practical healthcare solutions.
Further details are available on the Patent Mitra Portal.
For any queries, medical colleges/institutions may contact ICMR.
The Medical Innovations Patent Mitra is a Government of India initiative launched by the ICMR to provide end-to-end patenting and technology transfer support to biomedical researchers, medical institutions, and startups, translating indigenous lab research into real-world healthcare products. Guided by NITI Aayog and partnered with the Department of Pharmaceuticals (DoP) and DPIIT, the initiative bridges the gap between science and industry.
To view the advisory, click on the link below:
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.